BR112023025789A2 - Nitroxolina para uso no tratamento de neurofibroma cutâneo - Google Patents

Nitroxolina para uso no tratamento de neurofibroma cutâneo

Info

Publication number
BR112023025789A2
BR112023025789A2 BR112023025789A BR112023025789A BR112023025789A2 BR 112023025789 A2 BR112023025789 A2 BR 112023025789A2 BR 112023025789 A BR112023025789 A BR 112023025789A BR 112023025789 A BR112023025789 A BR 112023025789A BR 112023025789 A2 BR112023025789 A2 BR 112023025789A2
Authority
BR
Brazil
Prior art keywords
nitroxoline
treatment
cutaneous neurofibroma
neurofibroma
cutaneous
Prior art date
Application number
BR112023025789A
Other languages
English (en)
Portuguese (pt)
Inventor
David Brown
Original Assignee
Healx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Healx Ltd filed Critical Healx Ltd
Publication of BR112023025789A2 publication Critical patent/BR112023025789A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112023025789A 2021-06-09 2022-06-09 Nitroxolina para uso no tratamento de neurofibroma cutâneo BR112023025789A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2108224.3A GB202108224D0 (en) 2021-06-09 2021-06-09 Treatment
PCT/GB2022/051442 WO2022258972A1 (en) 2021-06-09 2022-06-09 Nitroxoline for use in the treatment of cutaneous neurofibroma

Publications (1)

Publication Number Publication Date
BR112023025789A2 true BR112023025789A2 (pt) 2024-02-27

Family

ID=76838879

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023025789A BR112023025789A2 (pt) 2021-06-09 2022-06-09 Nitroxolina para uso no tratamento de neurofibroma cutâneo

Country Status (12)

Country Link
US (1) US20240261276A1 (cg-RX-API-DMAC7.html)
EP (1) EP4351576A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024520690A (cg-RX-API-DMAC7.html)
KR (1) KR20240024175A (cg-RX-API-DMAC7.html)
CN (1) CN117769419A (cg-RX-API-DMAC7.html)
AU (1) AU2022290019A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023025789A2 (cg-RX-API-DMAC7.html)
CA (1) CA3221964A1 (cg-RX-API-DMAC7.html)
GB (1) GB202108224D0 (cg-RX-API-DMAC7.html)
IL (1) IL309177A (cg-RX-API-DMAC7.html)
MX (1) MX2023014530A (cg-RX-API-DMAC7.html)
WO (1) WO2022258972A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202116743D0 (en) * 2021-11-19 2022-01-05 Healx Ltd Treatment
GB202218460D0 (en) * 2022-12-08 2023-01-25 Healx Ltd Treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2970128B1 (en) * 2013-03-15 2019-12-04 Asieris Pharmaceutical Technologies Co., Ltd. Base addition salts of nitroxoline and uses thereof
CA3287905A1 (en) * 2016-10-14 2025-11-29 Wake Forest University Health Sciences Compositions, cell constructs, and methods of making and using the same
EP3883552B1 (en) * 2018-11-20 2025-04-09 NFlection Therapeutics, Inc. Cyanoaryl-aniline compounds for treatment of dermal disorders
CN112402388A (zh) * 2019-08-05 2021-02-26 江苏亚虹医药科技股份有限公司 一种用于治疗膀胱癌的口服固体制剂及其制备方法

Also Published As

Publication number Publication date
MX2023014530A (es) 2024-04-10
US20240261276A1 (en) 2024-08-08
JP2024520690A (ja) 2024-05-24
CA3221964A1 (en) 2022-12-15
WO2022258972A1 (en) 2022-12-15
CN117769419A (zh) 2024-03-26
EP4351576A1 (en) 2024-04-17
AU2022290019A1 (en) 2023-12-14
IL309177A (en) 2024-02-01
KR20240024175A (ko) 2024-02-23
GB202108224D0 (en) 2021-07-21

Similar Documents

Publication Publication Date Title
NZ777871A (en) Small molecule modulators of il-17
CL2021000382A1 (es) Compuestos novedosos de sulfonamidaurea
ZA202109010B (en) Compounds and methods for the treatment of covid-19
UA130338C2 (uk) Кон'югат ліганд-лікарський засіб аналога ексатекану, спосіб його отримання та його застосування
CL2018002009A1 (es) Compuestos derivados de ciclopentanoperhidofenantreno, moduladores de fxr; composicion farmaceutica que comprende dichos compuestos; y su uso para el tratamiento de enfermedades colestásicas, fibróticas, hipercolesterolemia, entre otras.
BR112019024831A2 (pt) composto, sal, solvato ou pró-droga, composição farmacêutica, método de tratamento ou prevenção de uma doença, método para inibir o nlrp3
CL2020000860A1 (es) Compuestos monobactámicos cromanos para el tratamiento de infecciones bacterianas.
MX2019012847A (es) Compuestos de c5-anilinoquinazolina y su uso en el tratamiento del cancer.
MX2023014492A (es) Compuestos utiles en la terapia para el vih.
MX2021013075A (es) Oxisteroles y metodos de uso de los mismos.
EA202192433A1 (ru) Соединения, полезные в терапии вич
BR112021011325A2 (pt) Derivados de rapamicina
BR112020008258B8 (pt) Compostos de biarila substituída ou seus sais farmaceuticamente aceitáveis, sua composição e seu uso como inibidores de indoleamina 2,3-dioxigenase (ido)
MY202753A (en) Griseofulvin compound and pharmaceutical use thereof
BR112019004236A2 (pt) compostos para tratar doenças associadas a uma disfunção mitocondrial
BR112022020933A2 (pt) Inibidores de replicação do vírus da imunodeficiência humana
MX2022000390A (es) Derivados macrociclicos espirociclicos como inhibidores de mcl-1.
BR112019018615A2 (pt) compostos antimicrobianos, composições e usos dos mesmos
MX2019011908A (es) Macrociclos de peptidos anti-bacterianos y uso de los mismos.
BR112022019864A2 (pt) Composto de oxofenilarsina deuterada e uso do mesmo
BR112018070536A2 (pt) composto, composição farmacêutica, combinação, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, método de tratamento de uma doença ou condição
BR112018070514A2 (pt) composto, composição farmacêutica, combinação, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, método de tratamento de uma doença ou condição
BR112017021583A2 (pt) métodos para o tratamento de transtornos inflamatórios
MX2023014530A (es) Nitroxolina para su uso en el tratamiento de neurofibroma cutaneo.
MX2024006105A (es) Nitroxolina para su uso en el tratamiento o prevencion de un neurofibroma plexiforme.